Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GABRG2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CDCA8 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ZC3HC1 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | OR51B5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | POLR3G | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | KRTAP4-8 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | FGF14 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | ZSCAN4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ANK2 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PRKD2 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |